18 October 2019
The Impact and Value of the NIHR Clinical Research Network (CRN) is an independent report, commissioned by the CRN and produced by KPMG’s Economics team. It provides an assessment of the economic impact of CRN activities to support clinical research in England over the period from 2016/17 – 2018/19. The report includes:
• an assessment of the economic contribution made to the UK economy through clinical research activity supported by the Network;
• analysis to quantify the value of payments made to NHS Trusts for commercial studies;
• analysis to quantify the value to the NHS of pharmaceuticals provided as part of commercial studies.
The same assessment was conducted by KPMG in 2016 and a similar report was published. The 2016 report described the value of the CRN Portfolio for FY2014/15, whereas the 2019 report covers three years of data (FYs 2016/17 – 2018/19) and yearly breakdowns to enable comparisons to be made with 2016 report.
The 2019 report uses the same methodology as the 2016 report (UK Government recognised appraisal methodologies set out in HM Treasury Green Book) and, although the report analyses all CRN support for clinical research, it has a specific focus on commercial clinical research.
The headline findings are good news and demonstrate growth for the CRN and the UK.
Please find the report attached and an infographic which summaries the key findings.
For more information, including comment from Jonathan Sheffield, read the news item on the NIHR website: